| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79395d65438e90d1e293da65b83edf14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e30429465aaa45e090b102dddccdb4d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df6ea2460095c7f1484e59b1e159e07b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4371d408d9e540157d6e64d43d44fefa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f69f4eb36a1cca3c0901b8d0820aea32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
2010-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce5c81928ceb45e9c4d19e43500b6de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfe3ccb4ba404db695b1a9d49d503ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b73df8b2f0764b38edb49db72846927
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_702637871ead620176794d393f3e0c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b636a3e0a781a7feb14e5c84ba299fee |
| publicationDate |
2010-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010303855-A1 |
| titleOfInvention |
Method of reducing adverse effects of therapeutic agents for dyslipidemia |
| abstract |
A substance preventing adverse actions of conventional fibrate-series drugs as therapeutic agents for the metabolic syndrome and dyslipidemia to enhance the therapeutic effects thereof comprises an extract from Dunaliella salina or Dunaliella bardawil , for administration in combination with the fibrate-series drugs. The substance suppresses liver hypertrophy caused by the fibrate-series drugs as PPAR-α agonists and has an action of promoting fat combustion, suppressing fat synthesis and suppressing cell proliferation, to prevent disorders of liver functions. |
| priorityDate |
2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |